P&F Products & Features GmbH is proud to announce that it has been awarded the esteemed Houska Prize for outstanding innovation and excellence in the “Research and Development in Small and Medium-Sized Enterprises (SME)” category. This recognition highlights the company’s dedication to pushing the boundaries of product development and its unwavering commitment to delivering exceptional solutions to treat mitral and tricuspid regurgitation.
The Houska Prize, Austria’s largest privately awarded prize fund for application-driven research, has been awarded annually by the B&C Private Foundation for outstanding research projects conducted in Austria since 2005. P&F Products & Features GmbH was selected for its groundbreaking TricValve® Transcatheter Bicaval Valve System* for the treatment of patients with hemodynamically relevant tricuspid insufficiency and caval reflux.
“We are honored and thrilled to receive the Houska Prize,” said President and Co-founder, Prof. Dr. Siegfried Einhellig. “This award is a testament to the hard work and creativity of our talented team. It reinforces our commitment to pushing the limits of innovation and developing solutions that transform patients’ lives and assist healthcare professionals in providing the best care. We look forward to further advancements in our field and are excited about the opportunities ahead.”
As a leader in minimally invasive structural heart devices, P&F Products & Features GmbH remains dedicated to fostering a culture of innovation and a patient-centered approach. With a strong focus on research and development, the company continues to set new benchmarks in medical innovation.
The Houska Prize is the latest in a series of prestigious awards and recognitions for TricValve. The company’s forward-thinking approach and its ability to adapt to changing market demands position it as a key player in cardiovascular medical technology.
For more information about P&F Products & Features GmbH and its award-winning products, please visit productsandfeatures.com.
About P&F Products & Features GmbH
P&F is a leading global medical technology company, commercially present in around 70 countries worldwide. The leadership team has built a complete infrastructure for research, development, manufacture, and distribution to deliver innovative technologies in cardiology. Headquartered in Vienna, Austria, P&F has operation facilities in Germany, Portugal, Spain, and Brazil. Discover more at www.productsandfeatures.com.
*CAUTION: The TricValve system is limited by U.S. Federal Law to investigational use. TricValve is CE marked and registered with ANVISA.